Antibacterial Resistance Leadership Group

Experts dedicated to prioritizing, designing, and executing clinical research that will reduce the public health threat of antibacterial resistance.

[Antibacterial Resistance Leadership Group @ARLGnetwork]

The #ARLGnetwork SCOUT-CAP study compared 5 days to 10 days of antibiotics to treat kids with pneumonia & found no significant differences in clinical outcomes. Results support shorter use of antibiotics, helping to reduce antibiotic resistance. Learn more https://t.co/MAVPEKua4m

[Antibacterial Resistance Leadership Group @ARLGnetwork]

CRACKLE-2 studied carbapenem-resistant Klebsiella pneumoniae in hospitals around the world. Results indicate the need for research & treatment strategies for CRKP to be tailored to specific regions & patient groups. Learn more: https://t.co/ViwGXzoySd
#AMR #IDTwitter

[International Society of Antimicrobial Chemotherap @ISAC_world]

ISAC congratulates Prof.Vance Fowler, 2026 recipient of the Hamao Umezawa Memorial Award, ISAC's highest honour for contributions to antimicrobial chemotherapy.
Prof. Fowler will deliver his award lecture at #ICC 2026 in Manila

📅 7–9 Dec 2026
More: https://t.co/TJmlFM8QnA

[Antibacterial Resistance Leadership Group @ARLGnetwork]

DYK? The #ARLGnetwork developed the Desirability of Outcome Ranking (DOOR) method to help doctors turn data from #ClinicalResearch into knowledge to customize treatments & improve outcomes for patients with bacterial infections. Learn more: https://t.co/nm9W2BNTwZ
#AMR #IDTwitter

[Antibacterial Resistance Leadership Group @ARLGnetwork]

Results of the #ARLGnetwork STAR study demonstrated that antibiotics for children with pneumonia should be decreased when possible. Shorter treatments that are still effective may reduce side effects & help combat antibiotic resistance. Learn more: https://t.co/gU1cDx0tiH
#AMR

[Antibacterial Resistance Leadership Group @ARLGnetwork]

Combining ceftazidime-avibactam and aztreonam could help tackle tough antibiotic-resistant infections. The #ARLGnetwork COMBINE studies explored the safest and most effective ways to use these drugs together. Learn more: https://t.co/4F7ALmOQvf
#AMR #IDTwitter

[Antibacterial Resistance Leadership Group @ARLGnetwork]

🔬The STEP FMT #ARLGnetwork study team is in writing mode! This mentee project examined how certain gut bacteria take hold after fecal microbiota transplantation – key to advancing microbiome therapeutics. Learn more about ARLG studies🔗https://t.co/ApwfdBXSP0

[Antibacterial Resistance Leadership Group @ARLGnetwork]

📄The #ARLGnetwork FAST study team submitted another manuscript! The study compared outcomes for patients who had rapid phenotypic antimicrobial susceptibility testing (AST) for #GramNegative bacteremia vs standard AST. Learn more about ARLG studies 🔗 https://t.co/6NfBZW65M9

[Antibacterial Resistance Leadership Group @ARLGnetwork]

💡The #ARLGnetwork’s DOOR paradigm puts patients at the center by evaluating both benefits and risks together, offering a more complete view of treatment impact. Learn more about this innovative, patient-focused approach to #ClinicalResearch🔗https://t.co/VO86KCWyyr

[Antibacterial Resistance Leadership Group @ARLGnetwork]

✅#ARLGnetwork DIFFR study researchers submitted a manuscript! This mentee project developed a new test for C. difficile that detects toxin mRNA in stool & compared its accuracy to gold standard methods. Learn more about ARLG studies 🔗https://t.co/sHF7LUdLJk

[Antibacterial Resistance Leadership Group @ARLGnetwork]

💡The #ARLGnetwork’s Drs. Angela Huttner, Tom Holland, & @davidantibiotic will join other experts in #InfectiousDiseases & #Microbiology in leading a 3-day @ESCMID postgrad course to train new researchers in all phases of clinical trials🔗https://t.co/2ZAbE3MEWB

[Antibacterial Resistance Leadership Group @ARLGnetwork]

🔍Innovative tests to quickly identify bacterial infections can save lives by helping doctors choose the best treatments for their patients. In this commentary, #ARLGnetwork members describe how new tests can be evaluated to ensure results are reliable🔗https://t.co/lqDmkp3Y7M

[Duke Clinical Research Institute @DCRINews]

The @ARLGNetwork recently had two studies featured in a late-breaking session at #ESCMID2026— highlighting global collaboration and evidence to fight antibiotic resistance. Learn more: https://t.co/SX386ihl7R

[Antibacterial Resistance Leadership Group @ARLGnetwork]

Heather Cross has been with the #ARLGnetwork since its inception in 2013. She oversees all ARLG operations, supports early career clinicians & leads talented teams conducting clinical trials to improve treatments for patients with bacterial infections🔗https://t.co/LGDSkTQcVa

[Antibacterial Resistance Leadership Group @ARLGnetwork]

📊Study Milestone: The #ARLGnetwork ESCAPED study is analyzing data! This mentee project aimed to describe the S. aureus #AMR patterns, risk factors, & antibiotic prescribing practices for patients in emergency departments. Learn more: https://t.co/ExI0lak7dh

[Antibacterial Resistance Leadership Group @ARLGnetwork]

DYK the #ARLGnetwork maintains a biorepository of bacteria for the #AMR community? 24 ARLG Klebsiella pneumoniae isolates were used in a research project to identify phages that could offer alternative treatment options for multi-drug resistant infections🔗https://t.co/dmhvW5sgPq

[Antibacterial Resistance Leadership Group @ARLGnetwork]

🎥ICYMI: Learn about cefepime vs piperacillin-tazobactam in adults hospitalized with acute infection in this recording of the #ARLGnetwork Grand Rounds, “The Why & How of the ACORN Trial,” presented by @EdQian & @toddrice_ICU, @VUMCDiscoveries: https://t.co/yzRKf5L8xm

[Antibacterial Resistance Leadership Group @ARLGnetwork]

🎉Congratulations to @lodise_tom, #ARLGnetwork’s Pharmacokinetic Lead, who received the @ASHPFoundation 2025 Literature Award for Sustained Contributions! Read about his impactful work to improve care for patients with #AMR infections: https://t.co/FvfTZw9gxo

[Antibacterial Resistance Leadership Group @ARLGnetwork]

Robin Patel, ARLG Lab Center Director, has been with the #ARLGnetwork since its inception in 2013. She’s committed to improving diagnostic techniques for #InfectiousDiseases & training the next generation of researchers in #AMR to advance patient care🔗https://t.co/Xbfn7xxBKl

[Antibacterial Resistance Leadership Group @ARLGnetwork]

The #ARLGnetwork will have a strong presence at #ESCMIDGlobal2026! We’re excited to join 16K doctors, researchers, & innovators in infectious diseases & clinical microbiology to share our expertise in #AMR. See a list of ARLG member presentations @ESCMID🔗https://t.co/sQRKnNjoso